NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biobytes

Biobytes

Private
ChuncheonHealthcare & Life Scienceshttps://www.biobytes.ai/en

Last Round

Early Funding

Jun 4, 2026

Total Funding Raised

$1.85M

Company Overview

Biobytes is a health technology company that develops AI-powered platforms for sarcopenia risk assessment, biomarker discovery, and muscle health management.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

sarcopenia predictionbiomarker discoverymedical AIbiobankAI diagnosticsprecision medicinedrug discoverydigital healthclinical decision supportmulti-omicshealthcare analyticsmuscle healthhealth techlongevity techdata as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biobytes Comparables

Compare Biobytes with similar companies based on industry and business-model similarity.

Biobytes comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomdcare Corporation
82%
IMOON HEALTHCARE Co., Ltd.
71%
ClariPi Inc.
68%

Biobytes Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 4, 2026
SeedNov 15, 2024

Key People

Founding team and executive leadership

Jaewon Kim

Co-Founder Vice President CTO

Founding Team

Jungwoo Lee

Chief Executive Officer

Executive Team

Biobytes Investors

Notable investors and investment history

Biobytes investors
InvestorRounds
KOTECEarly Funding
Gangwon Creative Economy Innovation CenterSeed
CNT TechSeed
Sopoong VenturesSeed
Newborn VenturesEarly Funding
Kingsley VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 6, 2026

    Grew 300% QoQ, from 3 to 12 employees.

Biobytes Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biobytes Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biobytes's valuation, stock price, and market status.

Firmographic Details

HeadquartersChuncheon
Employee Range12
Year Founded2023
Last FundingJun 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.